1. Philippe Birmes. Dominique Coppin.
Serotonin syndrome: a brief review. Canadian
Medical Association. 2003 May 27: 168(11)
2. Bettina C. Pretor (2006) Serotonyn
Síndrome. J Neurosci Nurs, 38 (2): 102-105
3. Weiner AL. Meperidine as a potential cause
of serotonin syndrome in the emergency
department. Acad Emerg Med 1999;6:156-8.
4. Isbister GK, Bowe SJ, Dawson A, et al.
Relative toxicity of selective serotonin
reuptake inhibitors (SSRIs) in overdose. J
Toxicol Clin Toxicol 2004;42:277-85.
5. Engbersen, et al. The serotonin síndrome.
Oct 2004; 62 (9).
6. (Philippe Birmes, Dominique Coppin, Laurent
Schmitt, Dominique Lauque. Serotonin syndrome: a
brief review CMAJ • MAY 27, 2003; 168 (11):
1439-1442 ).
7. (The Serotonin Syndrome Edward W. Boyer,
M.D., Ph.D., and Michael Shannon, M.D., M.P.H. N
Engl J Med 2005;352:1112-20.)
8. (Michael Ganetsky, D. Eric Brush D.
Clinical pediatric emergency Serotonin
Syndrome—What Have We Learned? p 104-108)
9. (Carrillo Esper R et al. Síndrome
serotoninérgico en la Unidad de Terapia
Intensiva. Rev Asoc Mex Med Crit y Ter Int
2008;22(2):93-98)
10. (CMAJ • MAY 27, 2003; 168 (11): 1439-1442
Serotonin síndrome: a brief review Philippe
Birmes, Dominique Coppin, Laurent Schmitt,
Dominique Lauque).
11. Fugh-Berman A. Herb-drug interactions.
Lancet 2000;355:134-8.
12. Mason PJ, Morris VA, BalcezaK TJ. Serotonin
syndrome. Presentation of 2 cases and review of
the literature. Medicine 2000;79:201-9.
13. Jaunay E, Gaillac V, Guelfi JD. Syndrome
sérotoninergique. Quel traitement et quand?
Presse Med 2001;30:1695-700.
14. Gillman PK. The serotonin syndrome and its
treatment. J Psychopharmacol. 1999;13:100-9.
15. Boyer EW, M.D. The Serotonin Syndrome. N
Engl J Med 2005; 352:1112-20
16. Bijl D. The serotonin syndrome.Netherlands
Drugs Bulletin 2003;37:82-85
17. Atilla RE;Meglathery SB. Serotonin Syndrome
and Other Serotonergic Disorders. Pain Medicine
2003;4:63-74.
18. Young P. Finn B.C. Síndrome serotoninérgico.
Presentación de cuatro casos y revision de la
literature. An. Med Interna 2008;25(3):125-130.
19. Bonetto N. Santelli L. Serotonin síndrome
and rhabdomyolisis induced by concomitant use of
triptans, fluoxetine and hypericum. Cephalalgia
2007;27:l421-1423.
20. Serotonin syndrome associated with triptan
monotherapy; N Eng J Med 358;20
21. Frank Christopher. Recognition and
treatment of serotonin síndrome. Can Fam
Physician 2008;54:988-92.
22. Ailawadhi S. Sung KW. Serotonin syndrome
caused by interaction between citalopram and
fentanyl. J of Clin Phaymacy and Therapeutics
2007;32:199-202.
23. Hegerl U. Bottlender R. The Serotonin
síndrome scale: first results on validity.Eur
Arch Psychiatry Clin Neurosci 1998;248:96-103.
24. Dvir Y., Smalwood P. . Serotonin syndrome: a
complex but easily avoidable condition. General
Hospital Psychiatry 2008; 30 :284-287.
25. M.E. Erro1, I. Gastón2, M.C. Navarro. Los
trastornos del movimiento en urgencias. An.
Sist. Sanit. Navar. 2008 Vol. 31, Suplemento 1.
26. Hoes MJAJM, Zeijpveld JHB. Mirtazapine as
treatment for serotonin syndrome.
Pharmacopsychiatry. 1996;29;81.
